***Background.*** The therapeutic response is monitored serologically after syphilis treatment. However, some patients remain serologically active despite treatment. We tried to identify the clinical characteristics associated with remaining serofast.

***Methods.*** We conducted a retrospective cohort study of patients treated for syphilis in Seoul National University Bundang Hospital. Factors related to the serological response after 1 year of treatment was analyzed. 4 folds decrease in nontreponemal antibody titer was regareded as serological cure and others as serofast.

###### 

Factors associated with remaining serofast, 1 year after treatment of the syphilis

                        Serofast (n=107)   Serological cure (n=47)   OR(95% CI)
  --------------------- ------------------ ------------------------- ----------------------
  Age Group                                                          
  10-29                 1(25.0%)           3(75.0%)                  1
  30-49                 17(50.0%)          17(50.0%)                 3.00(0.28-31.80)
  50-69                 50(71.4%)          20(28.6%)                 7.50(0.74-76.46)
  \>= 70                39(84.8%)          7(15.2%)                  16.71(1.51-184.60)
  Sex                                                                
  Male                  45(63.4%)          26(36.6%)                 1
  Female                62(74.7%)          21(25.3%)                 1.71(0.85-3.41)
  History of syphilis                                                
  No                    86(68.8%)          39(31.2%)                 1
  Yes                   21(72.4%)          8(27.6%)                  1.19(0.49-2.92)
  Stage                                                              
  Primary               0(0%)              4(100%)                   N/A
  Secondary             1(12.5%)           7(87.5%)                  1
  Early latent          7(87.5%)           7(87.5%)                  3.11(0.28-34.42)
  Late latent           102(79.7%)         26(20.3%)                 27.46(3.23-233.19)
  Tertiary              0(0%)              1(100%)                   N/A
  Initial RPR titer                                                  
  1:1                   40(81.6%)          9(18.4%)                  26.67(2.85-249.76)
  1:2                   24(92.3%)          2(7.7%)                   72.00(5.56-932.99)
  1:4                   18(94.7%)          1(5.3%)                   108.00(5.81-2005.95)
  1:8                   13(76.5%)          2(23.5%)                  19.50(1.78-213.95)
  1:16                  11(68.8%)          5(31.3%)                  13.20(1.24-140.68)
  1:32                  1(14.3%)           6(85.7%)                  1
  \>=1:64               0(0%)              11(100%)                  N/A

Abbreviations: CI, confidence interval; OR, odds ratio; RPR, rapid plasma regain; N/A, not applicable

***Results.*** A total of 154 HIV negative patients with primary, secondary, tertiary and latent syphilis were included in the final analysis. Among them, 107 patients remained serofast and the other 47 patients showed serological cure. Older patients and patients with later disease stage were more likely to remain serofast. Having initial nontreponemal antibody titer of 1:2 and 1:4 was also associated with the serofast.

***Conclusion.*** The disease stage, age and initial nontreponemal antibody titer were important factors related to the serological response.
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